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a  b  s  t  r  a  c  t
Perﬂuoralkylated  substances  (PFAS)  are  classiﬁed  as  persistent,  bioaccumulative  and toxic  substances  and
are widespread  environmental  contaminants.  Humans  are  exposed  through  food,  drinking  water  and  air.
We have  previously  reported  that bisphenol  A  accelerates  spontaneous  diabetes  development  in  non-
obese  diabetic  (NOD)  mice  and  observed  in the  present  study  that  perﬂuoroundecanoic  acid,  PFUnDA,
increased  insulitis  development,  a prerequisite  for diabetes  development  in NOD  mice.  We exposed  NOD
mice  to PFUnDA  in  drinking  water (3, 30 and  300  g/l)  at mating,  during  gestation  and  lactation  and
until  30 weeks  of  age.  After  300  g/l PFUnDA  exposure,  we  report  (i)  increased  pancreatic  insulitis,  (ii)
increased  number  of apoptotic  cells  in  pancreatic  islets  prior  to  insulitis  and (iii) decreased  phagocytosis
in  peritoneal  macrophages.  There  was  also  a trend  of decreased  number  of  tissue  resident  macrophages
in  pancreatic  islets  prior  to insulitis  after  exposure  to 300  g/l,  and  altered  cytokine  secretion  in activated
splenocytes  after exposure  to 3  g/l PFUnDA.  Although  insulitis  is a prerequisite  for autoimmune  dia-
betes,  the  accelerated  insulitis  was  not  associated  with  accelerated  diabetes  development.  Instead,  the
incidence  of  diabetes  tended  to  be  reduced  in  the  animals  exposed  to  3 and  30 g/l PFUnDA,  suggesting
a  non-monotonic  dose  response.  The  effects  of PFUnDA  exposure  on increased  apoptosis  in pancreas
and  reduced  macrophage  function  as  well  as accelerated  insulitis  development  in  NOD  mice,  may  also
be  relevant  for  human  insulitis.  Further  observational  autoimmune  diabetes  clinical  cohort  studies  and
animal  experiments  for PFUnDA  as  well  as other  PFASs  are  therefore  encouraged.
© 2016  Norwegian  Institute  of  Public  Health.  Published  by  Elsevier  Ireland  Ltd.  This  is an  open  access
he CCarticle  under  t
. Introduction
Development of type 1 Diabetes Mellitus (T1DM) involves
utoimmune destruction of pancreatic beta-cells, leading to insulin
eﬁciency, with a disease development at early age in genetically
redisposed individuals. There is evidence for genetic predisposi-
ion, but the increased incidence of T1DM worldwide suggests a
ole of environmental factors in triggering disease development
reviewed in [7,9]. Lack of speciﬁc nutrients during pregnancy (e.g.
itamin D and long chain n-3 fatty acids) and viral infection during
arly life as well as exposure to N-nitroso compounds, air pollutants
nd persistent organic pollutants have been suggested to inﬂuence
1DM development in epidemiological studies [39,61,32]. There
re however limited numbers of epidemiological studies investi-
ating association between T1DM and environmental factors and
ausal experimental data is sparse [9].
∗ Corresponding author.
E-mail address: johannabodin74@gmail.com (J. Bodin).
ttp://dx.doi.org/10.1016/j.toxrep.2016.08.009
214-7500/© 2016 Norwegian Institute of Public Health. Published by Elsevier Irela
reativecommons.org/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Environmental toxins, as baﬁlomycin from Streptomyces
infected vegetables, as well as the toxicant rodenticide Vacor, are
reported to speciﬁcally decrease beta-cell function and to accel-
erate diabetes type 1 development in non-obese diabetic (NOD)
mice, a model for T1DM [31,44], illustrating that environmental
chemicals can promote T1DM development in this animal model
[9].
Further, we have in earlier studies shown that exposure to
bisphenol A (BPA) accelerates spontaneous diabetes development
in NOD mice [6–8]. One mechanism of this accelerated diabetes
development due to BPA exposure was suggested to be reduced
phagocytosis by macrophages [6], leading to increased number of
apoptotic cells in the pancreas and thereby accelerated insulitis
development. Impaired macrophage phagocytosis was also seen
after in vitro BPA exposure in peritoneal macrophages from both
non-exposed C57/Bl6 mice and Wistar rats (Friis Berntsen et al.
manuscript submitted for publication). In that study, we also
observed a reduced phagocytosis in isolated mouse and rat peri-
toneal macrophages after in vitro exposure to the perﬂuorinated
compound perﬂuoroundecanoic acid (PFUnDA), to a similar degree
nd Ltd. This is an open access article under the CC BY-NC-ND license (http://
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s observed after BPA exposure. Other perﬂuoroalkyl and polyﬂuo-
oalkyl substances (PFASs) like PFOS, PFNA and PFDA did not impair
acrophage function to the same extent Reduced macrophage
hagocytosis is one of several mechanisms in T1DM development
n NOD mice [48]. Thus, we hypothesized that exposure to PFUnDA,
ia impaired macrophage function, will accelerate insulitis and
1DM in the NOD mouse model.
PFASs are substances with lipid- and water-repelling proper-
ies and are used in a wide range of consumer and industrial
roducts including non-stick, stain-repellent, water-repellent, and
re-retardant coatings [41]. PFASs are classiﬁed as persistent, bio
ccumulative and toxic substances. Humans are exposed through
ntake of marine food and game, but also via air and dust from
he indoor environment [30]. PFASs have been detected in human
erum, breast milk and adipose tissue in more than 98% of the
nalysed samples. The previously most used PFASs, like perﬂuo-
ooctane sulfonate (PFOS) and perﬂuorooctanoic acid (PFOA) have
ue to their known toxicity now widely been replaced in many
onsumer products with PFASs with longer carbon-chains, like
FUnDA. A longer ﬂuorinated carbon chain has however been
ssociated with increased toxicity [24,37,49]. The increased use
f PFUnDA is accompanied by an increased PFUnDA serum level,
ith an increase (8%) in human sera in Northern Norway between
001 and 2007 [46]. Typical mean human serum levels reported for
FUnDA are 0.1–0.4 ng/ml and maximal levels 0.70–1.4 ng/ml, com-
ared to 11–23 ng/ml and 3–9 ng/ml for maximal PFOS and PFOA
erum levels respectively [11,25,36,46,52,58,62].
Epidemiologic studies report immunosuppressive effects of
FAS, measured as associations between PFAS serum levels and
educed vaccine response and increased risk of infections in
arly childhood [26,27]. Although the evidence from epidemio-
ogic studies regarding the association between PFAS exposure
nd asthma and allergy is inconsistent, the available data sug-
est that PFAS exposure is associated with immunotoxic effects
2,3,17,27,33,50,59,64]. Studies of immunotoxic effects of PFASs
elated to autoimmunity are, however, sparse, but recently, higher
FOS serum levels have been reported in T1DM patients compared
o controls [54]. The aim of the present study was to investi-
ate the effect of one selected PFAS, PFUnDA, on early stages of
1DM development in the NOD mouse model. PFUnDA was chosen
ince it is one of the PFASs with rising exposure levels [46], and
ince it was shown to impair macrophage function in our in vitro
ystems.
. Material and methods
.1. Mice and exposure conditions
Female (94) and male (46) NOD/ShiLtJ mice from Jackson Labo-
atory (Maine, USA) were used for breeding at 8 and 10 weeks of age,
espectively. The female mice were randomized into 4 groups that
ere exposed through drinking water from the time of mating and
hroughout the life time of the offspring. The mating period was set
o one week with vaginal plug-check twice a day and exchange of
ales if no vaginal plug was detected during the ﬁrst two  days. The
ales were euthanized after the mating period of one week. The 4
xposure groups included: (1) negative control (autoclaved water
nly), (2) PFUnDA3 g/ml (CAS: 2058-94-8, >96% purity, Santa Cruz
iotechnology, Dallas, US), (3) PFUnDA 30 g/ml and (4) PFUnDA
00 g/ml. The exposure doses correspond to about 0.417, 4.17
nd 41.7 g/kg bw/day (calculated based on mean mouse weight
f 23 g and mean measured volume of drinking water consump-
ion of 3.2 ml/day at 10 weeks of age). The lowest exposure level
f PFUnDA was chosen at a dose corresponding to 3 times the
DI (tolerable daily intake) for PFOS (0.15 g/kg bw/day as setorts 3 (2016) 664–672 665
by EFSA [18]), since there is no TDI or estimated intake available
for PFUnDA. Estimated total intake of PFOS and PFOA is reported
to be between 0.71–2 and 13–83 ng/kg bw/day respectively in
adults, while calculated levels in infants ranges between 9.4–26
and 13–83 ng/kg bw/day respectively for PFOS and PFOA [23,30].
The lowest exposure dose chosen for PFUnDA to NOD mice in this
study is in the range of human environmental exposure, about ﬁve
times higher than the maximal calculated intake of PFOA in human
infants.
Only female offspring were selected at the time of weaning,
since insulitis and diabetes development is most prevalent in
female mice [35]. The perﬂuorinated substance PFUnDA was dis-
solved in deionized autoclaved water heated to 60 ◦C. Controls
received similar water without PFUnDA. The water bottle was
changed once every second week and ﬁlled up once a week. The
mice had ad libitum access to feed (Harlan Teklad 2919 irradi-
ated) and water and were exposed to a 12 h light/12 h dark cycle
and 35–75% humidity. To keep the dams as the statistical unit,
female siblings from each dam were separated and divided into
two sub-groups, 4–5 mice per cage; (i) short term exposure for
histological examination, splenocyte and peritoneal macrophage
function and (ii) long time exposure for diabetes incidence surveil-
lance. The short term exposure group was  divided into groups
with exposure until 7 and 11 weeks of age, used for histolog-
ical examination of pancreas and collection of splenocytes and
peritoneal macrophages. All experiments were performed in con-
formity with the laws and regulations for experiments with live
animals in Norway and were approved by the local representa-
tive of the Norwegian Animal Research Authority (FOTS number
6687).
2.2. Serum glucose measurements
Serum glucose was monitored weekly (from 6 to 30 weeks of
age) in female offspring in the long term exposure group in blood
sample from vena saphena using an Accu-Check Aviva blood glucose
meter (Roche Diagnostics GmbH, Mannheim, Germany). Animals
with two  subsequent (with 24 h interval) glucose measurements
at or above 13.9 mmol/l were considered diabetic, and were euth-
anized.
2.3. Histological evaluation
For histological evaluation, pancreas were collected from 8
mice (at 7 and 11 weeks of age respectively), ﬁxed in formalin,
embedded in parafﬁn and processed as previously described before
hematoxylin and eosin staining [8]. For each mouse 6 sections at
different depth of the pancreas were examined and all islets present
in the sections (10–15 islets/section) were graded for insulitis
according to the area of an islet inﬁltrated by lymphocytes. 0%
inﬁltration = grade 0, periinsulitis and up to 10% inﬁltration = grade
1, 10–49% inﬁltration = grade 2, 50–74% inﬁltration = grade 3 and
75–100% inﬁltration = grade 4, as illustrated previously in [8]. For
each section, an overall grade was  assigned which correlated to the
highest grade detected in at least 3 islets, since all pancreas samples
studied had islets with all insulitis grades represented. Then, the
ﬁnal grade for each pancreas/mouse was set to the highest grade
determined for the 6 analysed sections. The mean insulitis grade
for each exposure group corresponds to the mean of the ﬁnal grade
for each pancreas/mouse.
Sections of the formalin ﬁxed pancreas were also stained over-
night with antibodies towards F4/80 (tissue resident macrophages,
AbD Serotec, Oxford, UK, 1:50) and active caspase-3 (apoptotic
cells, Cell Signalling Technology, Beverly, MA,  USA, 1:400), as previ-
ously described [8]. For each antibody staining and insulitis grade,
the number of positive cells per islet was  counted in two  pancreatic
666 J. Bodin et al. / Toxicology Reports 3 (2016) 664–672
Fig 1. Insulitis grade in pancreas from female NOD mice after PFUnDA exposure (0, 3, 30 and 300 g/ml in drinking water) starting from before gestation and continuing
until  termination at 7 and 11 weeks of age. (A) Formalin ﬁxed pancreas were sectioned and stained with hematoxylin and eosin and evaluated for severity of inﬁltrating
lymphocytes using light microscopy (n = 8). Grade 0 = no inﬁltration, score 1 = periinsulitis to 10% inﬁltration, grade 2 = 10–50% inﬁltration, grade 3 = 50–75% inﬁltration and
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rade  in NOD mouse pancreas at 7 and 11 weeks of age (n = 8), presented as group
ancreatic islets showing insulitis grade 0–4. Scale bar indicates 40 m.  *Indicate s
ections per mouse. The counts per islet were compared between
he exposure groups according to the insulitis grade of each islet.
ince most female NOD mice spontaneously develop insulitis with
ge, the pre-insulitis islets are expected to give most information
n early accelerating effects, thus results from islets with grade 0
re presented.
.4. Phagocytic function of peritoneal macrophages
Peritoneal macrophages were collected from mice at 7 and
1 weeks (n = 8 for both time points) by peritoneal lavage with
n total 6 ml  PBS as previously described [6]. The cell suspen-
ion was centrifuged at 250 × g for 10 min  and erythrocytes were
emoved by dissolving the cell pellet in 0.2% NaCl on ice for
 min. The cell number was  determined by a cell counter (Coulter
1, Beckman Coulter Corporation, Miami, Florida) and cells were
eeded at 2 × 106 cells/ml in 48 wells plates with RPMI cell culture
edium (Biowest, Nuaillé, France). After 1 h in culture, 85–95% of
he attached cells are assumed to be macrophages [55]. Then the
edium with unattached cells was discarded, replaced with fresh
edium, and the cells were incubated over night to assess viable
ells. To analyse the phagocytic function, FITC-labelled Zymosan
articles were added at a ratio of 20 particles per cell (Invitrogen
ife Technologies, Carlsbad, California, United States) and incu-
ated for 30 min  at 37 ◦C. The cells were carefully washed twice
n PBS and incubated with Accutase (In vitrogen Life Technologies)
or at least 15 min  to remove particles from the cell surfaces and to
etach cells. Thereafter, the cells were washed twice with PBS, ﬁxed
n 0.2% paraformaldehyde in RPMI 1640 phenol red-free cell cul-
ure medium (Biowest) and analysed for phagocytic activity (FITC
ntensity per cell) by ﬂow cytometry (LSR II, BD Bioscience, Franklin
akes, NJ, USA). respective insulitis grades within the four exposure groups. (B) Average insulitis
 ± SEM. (C) Representative histological sections of hematoxylin and eosin-stained
ant difference from the control group, p < 0.05.
2.5. Cytokine secretion from ex vivo stimulated splenocytes
Splenocytes were isolated from 7 and 11 weeks old mice (n = 8)
as previously described [7]. Then, cytokine secretion upon ex vivo
stimulation with LPS or Concanavalin A (ConA) was determined
for all exposure groups, to examine possible effects on systemic
immune functions, as described previously [8,29]. Stimulation with
LPS for 48 h activates B-cells and macrophages (10 g/ml, Sigma
Aldrich, GmbH Steinheim, Germany), while ConA stimulation for
48 h activates T-cells (50 g/ml, Sigma Aldrich). The cytokine levels
(INF, TNF, IL-1, IL-2, IL-4, IL-6, IL-10, IL-13 and IL-17) in the
supernatants from stimulated splenocytes were determined with
cytometric bead array (FlexSet, BD Bioscience) analysed on a LSRII
ﬂow cytometer (BD Bioscience).
2.6. Statistical analysis
Data are presented as group means ± standard errors of the
mean (SEM). Differences in diabetes incidence between exposure
groups were investigated by Cox regression analysis, while all other
data sets were analysed by one-way analysis of variance (ANOVA),
using SigmaPlot13.0 software. The Holm–Sidak post hoc test was
performed to evaluate signiﬁcant differences between the exposure
groups. For all analyses, p-values <0.05 were considered statisti-
cally signiﬁcant.
3. ResultsThe litter size and sex ratios were not different between the
exposure groups (data not shown). Analysis of early signs of dia-
betes development in the NOD mice, expressed as alteration in
pancreatic histology at 7 and 11 weeks of age, revealed an increased
J. Bodin et al. / Toxicology Reports 3 (2016) 664–672 667
Fig. 2. Histological changes in pancreatic islets after exposure to 0, 3, 30 and 300 g/ml PFUnDA in drinking water, starting from before gestation and continuing until
termination (A) Mean number of tissue resident macrophages (F4/80 positive cells) in pancreatic islets prior to insulitis (grade 0) from 7 and 11 weeks old female NOD mice
(group  mean ± SEM, n = 8). (B) Mean number of active caspase-3 positive cells in pancreatic islets with insulitis grade 0 from 7 and 11 weeks old female NOD mice after
PFUnDA exposure (group mean ± SEM, n = 8). *Indicates signiﬁcant difference from the control group p < 0.05. C) Representative pancreatic islets immunostained for tissue
resident  F4/80 positive macrophages from control and PFUnDA 300 g/l exposed mice and apoptotic active caspase-3 positive cells respectively (D). Scale bar indicates
40  m.
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tig. 3. Peritoneal macrophage phagocytosis of FITC-conjugated Zymosan beads at 7
n  drinking water), % phagocytic macrophages determined by ﬂow cytometry (grou
nsulitis grade after high PFUnDA exposure (Fig. 1). This was  sig-
iﬁcant at 11 weeks of age, and a trend was also observed at 7
eeks of age. As expected due to the spontaneous T1DM devel-
pment in NOD mice, the degree of insulitis was increased from 7
o 11 weeks age, in all treatment groups. Further, immunohisto-1 weeks of age in female NOD mice after PFUnDA exposure (0, 3, 30 and 300 g/ml
n ± SEM, n = 8).
logical analysis of the number of tissue resident macrophages in
pancreatic islets prior to insulitis (in islets with insulitis grade 0)
indicated a decreased number of F4/80+ macrophages with increas-
ing PFUnDA exposure at both 7 and 11 weeks of age, although it did
not reach statistical signiﬁcance (Fig. 2a). The number of apoptotic,
668 J. Bodin et al. / Toxicology Reports 3 (2016) 664–672
Fig. 4. Spontaneous cumulative diabetes incidence, shown as percentage of diabetic female NOD mice exposed to PFUnDA in the drinking water from before gestation and
throughout life (n = 25), panel A. Diabetes was diagnosed when the blood glucose levels was  above 13.9 mmol/l. Glucose levels at 10, 20 and 30 weeks of age for all exposure
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00  g/l PFUnDA exposure group.
ctive caspase-3 positive cells, in pancreatic islets was  signiﬁcantly
ncreased prior to insulitis in pancreas at 11 weeks of age due to
igh PFUnDA exposure (Fig. 2b).
Phagocytic activity in isolated peritoneal macrophages from ani-
als after in vivo PFUnDA exposure was reduced, although not
igniﬁcantly, in the highest exposure group at 7 weeks of age, com-
ared to the control, with 42.9 ± 4.4% and 49.1 ± 5.6% phagocytic
ells respectively (Fig. 3).
Diabetes incidence cumulatively increased from 15 weeks of
ge. It was not signiﬁcantly different between the exposure groups,
lthough the low and intermediate exposures seemed to delay
he spontaneous diabetes development (Fig. 4). The blood glucose
evels for the NOD animals were low (typically between 5 and
 mmol/l) until week 15 when diabetes onset started to appear.
ost often, the individual levels changed from normal values to
bove 13.9 (diabetes diagnosis) within a week or two. This fast rise
n glucose level explains the relatively few animals with an inter-
ediate glucose level (at week 20 and 30; Fig. 4B) and the small
hange in the group median values unless the majority of the ani-
als were displaying diabetes. Early signs of diabetes are decreased
ody weight, polyuria and increased water intake [68]. The body
eight and water intake/mouse/day analysed at 10 and 20 weeks
f age did not differ between the exposure groups (data not shown).
Ex vivo in vitro LPS and ConA-induced cytokine secretion in
solated splenocytes revealed signiﬁcant differences between the
xposure groups (Fig. 5), seen as increased ConA-induced IL2-
ecretion and reduced LPS-induced IL-6 secretion upon the low-
st in vivo PFUnDA exposure. There was also a trend of increased
onA-induced IL-6 and IFN secretion from splenocytes from ani-
als with the highest in vivo PFUnDA exposure. There were no
igniﬁcant effects of PFUnDA exposure on the induced secretion
f TNF, IL-1, IL-4, IL-10, IL-13 and IL-17 (data not shown).
. DiscussionIn this study, peroral PFUnDA exposure during gestation, lac-
ation and throughout life increased pancreatic insulitis, impaired
eritoneal macrophage phagocytosis and altered cytokine secre-
ion in splenocytes, mechanisms involved in type 1 diabetesated due to diabetes diagnosis. The dotted line represents diabetes diagnosis. The
g/l PFUnDA exposed mice, the green line/dots 30 g/l PFUnDA and blue line/dots
development in NOD mice, but did not increase the incidence of
diabetes.
4.1. Insulitis development
The accelerated insulitis development due to high PFUnDA
exposure in NOD mice was shown to be associated with a reduced
number and/or function of tissue resident macrophages in pancre-
atic islets prior to insulitis, which may lead to an increased number
of apoptotic cells and autoantigens present for autoimmune T-cell
activation. These effects in the pancreas showed an apparent dose-
response relationship. Insulitis has been reported in the NOD mouse
model, as early as at 4 weeks of age [5]. It has been shown that
severe insulitis leads to T1DM development via inﬁltrating den-
dritic cells that activate autoreactive T-cells subsequently causing
reduced beta-cell number for sufﬁcient insulin production [56].
Impaired macrophage phagocytosis and reduced clearance of
apoptotic cells is one mechanism contributing to insulitis devel-
opment [47]. We  have previously identiﬁed the apoptotic cells
in pancreatic islets prior to insulitis as beta-cells, alpha-cells and
tissue resident macrophages [8]. The presently observed increase
in apoptotic cells in pancreatic islets prior to insulitis could be a
result of a lower number or reduced phagocytic function of tissue
resident macrophages, or direct cytotoxicity of PFUnDA exposure.
In fact, we did observe an apparent reduction in the number of
tissue resident macrophages in pancreatic islets prior to insuli-
tis, and impaired phagocytic function in peritoneal macrophages
at 7 weeks of age after PFuNDA exposure. The same trend was
not seen for macrophage function at 11 weeks of age, consistent
with previous data on BPA exposure showing that an accelerated
diabetes incidence was  associated with reduced phagocytosis func-
tion in peritoneal macrophages from mice at 7, but not 11 weeks
of age [6]. It has been reported that the majority of the murine
peritoneal macrophages have high expression of F4/80 [12], a sim-
ilarity in phenotype to tissue resident macrophages in pancreatic
islets. Decreased phagocytic function in peritoneal macrophages
may  therefore be a good surrogate marker for a reduced phago-
cytic function also in macrophages in the pancreas, a mechanism
J. Bodin et al. / Toxicology Reports 3 (2016) 664–672 669
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estation and until termination at 11 weeks of age (group mean ± SEM, n = 8). LPS
hown  in B, D and F (all cultures stimulated for 48 h). *Indicates signiﬁcant differen
ssociated with T1DM development that may  be similar between
OD mice and humans.
.2. Diabetes development
Increased insulitis grade at 11 weeks of age in female NOD
ice has previously been associated with an accelerated dia-
etes development [6–8] via inﬁltrating dendritic cells that
ctivate autoreactive T-cells subsequently causing reduced beta-
ell number for sufﬁcient insulin production [56]. Surprisingly, the
ccelerated insulitis in the present study due to the highest PFUnDA
xposure was not accompanied with an accelerated diabetes devel-
pment. The low and intermediate PFUnDA exposure doses even
eemed to have a delaying effect on the diabetes development, mice, exposed to PFUnDA (0, 3, 30 and 300 g/ml in drinking water) from before
ed cytokine release is shown in A, C and D and ConA-induced cytokine release is
 the control group, p < 0.05.
although not statistically signiﬁcant. This may  be explained by dif-
ferent modes of action of PFASs (as discussed below) including
mechanisms contributing to lowering the glucose levels at lower
PFUnDA doses. The PFuNDA exposure levels for humans are on a
rise [46] and the doses used in this study is regarded to be within a
relevant range, starting from 3 times higher than the tolerable daily
intake (TDI) available for PFOS and with maximal reported PFUnDA
serum levels of about 4–11% of the PFOS levels [25,36,52].
It has been shown that severe insulitis leads to T1DM devel-
opment via inﬁltrating dendritic cells that activate autoreactive
T-cells subsequently causing reduced beta-cell number for sufﬁ-
cient insulin production. The molecular mechanisms involved in
previously reported the immunotoxic effects of PFASs has been
hard to establish [34]. However, our results from the T1DM mouse
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odel is important in light of the recently reported epidemiolog-
cal observation that PFOS serum levels were elevated in T1DM
atients compared to controls [54] and the similarities in histol-
gy and immunity of disease development between human and
OD mice [63].
.3. Cytokine secretion
In addition, PFUnDA treatment also showed different effects
n IL-2, IL-6 and IFN cytokine secretion from splenocytes at
ow compared to high PFUnDA exposure doses. PFUnDA induced
n increase in ConA-induced IL-2 secretion and decreased LPS-
nduced IL-6 secretion at the low dose and an apparent increase
n ConA-induced IL-6 and IFN secretion at the high dose (also dis-
ussed below). Higher IFN secretion in pancreatic islet inﬁltrates
n female compared to male NOD mice is reported by others and
his enhancement of Th1 immune response was suggested to be
esponsible for the higher T1DM incidence always seen in female
ompared to male NOD mice in spite of similar degree of insuli-
is [5,57]. The present observed differences in cytokine secretion
t different exposure doses could indicate a non-monotonic dose
esponse, with different receptor activation or different receptors
eing activated at different exposure levels. A similar response
as been suggested after BPA exposure inducing insulin release
n beta-cells via estrogen receptors at high exposure levels and
strogen like-receptor at lower doses [1,8,45]. Activation of estro-
en receptors in the NOD mouse has been reported to reduce
he spontaneous diabetes incidence [4,14,21]. PFASs can activate
eroxisome proliferator-activated receptor alpha, PPAR, consti-
utive androstane receptor (CAR) and the pregnane receptor (PXR).
inding of these receptors have been shown to result in different
ellular responses, such as cellular stress, toxicity, induction of hep-
tic CYP2B enzymes, epigenetic changes and cytokine or insulin
ecretion, inhibition of tight junctional intercellular communica-
ion or alterations in circulatory miRNA [16,19,66]. It has also been
eported that PFOS exposure modulates calcium homeostasis in the
pleen, leading to induction of cytotoxic T-cells [42], cells that are
nvolved in driving autoimmune reactions.
PFAS exposure of human leukocytes in vitro has been reported
o increase IL-6 and TNF cytokine secretion [10,15], whereas after
n in vivo challenge IL-6 production by B cells was decreased
n B6C3F1mice [20]. Our results are in line with these in vivo
esults, showing decreased LPS-induced IL-6 secretion from iso-
ated splenocytes at the low dose in vivo PFUnDA exposure. PFAS
n vivo exposure has also been reported to reduce secretion of Th1
ytokines (IL-2 and INF) in favour of Th2 cytokines (IL-4, IL-10)
n C57BL/6 mice [67]. However, our ﬁnding of increased ConA-
nduced IL-2 cytokine secreted from isolated splenocytes after low
n vivo PFUnDA exposure is contrary to that report. These dif-
erences may  be related to varying receptor activation between
ifferent mouse strains [13]. However, IL-2 is important for the
omeostasis of regulatory T-cells (Tregs) [43], and the observed
ncrease in IL-2 signal could contribute to expand the Treg pool.
ikewise, lowered IL-6 signalling would favour Treg differentiation,
ince IL-6 inﬂuence the balance between Treg/Th17cells favouring
he differentiation of Th17 cells [22,38]. Thus, we can speculate that
he observed reduction in IL-6 and increase in IL-2, via Treg upreg-
lation could have contributed to a protective effect on diabetes
evelopment in the NOD mouse, as seen after low dose PFUnDA
xposure.
Only a few studies have been performed with regard to effects
nd mechanisms of PFUnDA. Higher maternal serum level of
FUnDA has been associated with decreased maternal and cord
lood thyroid hormones [65] and alterations in thyroid hormone
omeostasis during fetal development may  affect fetal growth,
euronal development and glycaemic control [28]. In hypothy-
[orts 3 (2016) 664–672
roidism a reduced rate of liver glucose production is observed and
accounts for a decrease in insulin requirement [51]. If PFUnDA
exposure results in altered thyroid hormone homeostasis and
potentially decreased insulin requirement, this may  be one mech-
anism explaining how PFUnDA exposure did reduce diabetes
development in the low and medium dosed NOD mice, although
with possible counteracting immunotoxic effects, like increased
insulitis, at higher exposure doses. In humans, imbalance in thy-
roid homeostasis is often seen in T1DM patients (hyper-as well
as hypothyroidism) [60]. Further, prenatal PFUnDA-exposure was
reported to be associated with lower birth weight [40] and an
upregulation of immunomodulatory genes were associated with
a range of prenatal PFASs exposure [53].
In conclusion, we have shown that PFUnDA exposure during
gestation, lactation and early life accelerates pancreatic insulitis
development, decreases peritoneal macrophage phagocytosis and
alters splenocyte cytokine secretion in a mouse model of T1DM.
This may  suggest that PFUnDA also have similar effects on insuli-
tis development in humans and possible consequences for human
T1DM development. Therefore, further epidemiological investiga-
tions of associations between PFUnDA and other PFAS exposures
and T1DM development are encouraged.
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